These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17205454)

  • 21. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
    Nnoruka EN; Chukwuka JC; Anisuiba B
    Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
    Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
    Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand.
    Pattanapanyasat K; Shain H; Noulsri E; Lerdwana S; Thepthai C; Prasertsilpa V; Likanonsakul S; Yothipitak P; Nookhai S; Eksaengsri A
    Cytometry B Clin Cytom; 2005 May; 65(1):29-36. PubMed ID: 15800883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS?
    Jibrin YB; Yusuph H; Garbati MA; Gashau W; Abja UM
    Afr J Med Med Sci; 2006 Mar; 35(1):9-13. PubMed ID: 17209321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar. SIDAK Research Group.
    Kony SJ; Hane AA; Larouzé B; Samb A; Cissoko S; Sow PS; Sané M; Maynart M; Diouf G; Murray JF
    J Infect; 2000 Sep; 41(2):167-71. PubMed ID: 11023763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group.
    Gorham ED; Garland FC; Mayers DL; Goforth RR; Brodine SK; Wiess PJ; McNally MS
    Arch Intern Med; 1993 Apr; 153(7):869-76. PubMed ID: 8096691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
    Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
    Netski DM; Mosbruger T; Astemborski J; Mehta SH; Thomas DL; Cox AL
    J Infect Dis; 2007 Mar; 195(6):857-63. PubMed ID: 17299716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of clinical and laboratory surrogate markers of immunodepletion with T cell subsets (CD4 & CD8) determined flow cytometrically in HIV infected patients: a hospital based study.
    Uppal SS; Gupta S; Verma S
    J Commun Dis; 2003 Sep; 35(3):140-53. PubMed ID: 15796406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of CD4 counts and percentages in the HIV infected Indian population.
    Vajpayee M; Kanswal S; Wig N; Seth P
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):144-6. PubMed ID: 15272758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
    Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
    J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
    Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
    Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.